Is wholesale distribution the best option for drug manufacturers?In today’s market, customer mergers and consolidations leave drug manufacturers few options in establishing a distribution strategy to make their products available and remain profitable. The popular...
2023 Final Rule Updates for Drug Manufacturers Originally published March 2022; updated May 2022UPDATE May 18, 2022 2023 was shaping up to be a year of challenging decisions for manufacturers and restricted access to critical pharmaceuticals for patients. The 2023...
Letting some air out of the AMP inflation penalty.As of late, we have all been bombarded by headlines lamenting or explaining the recent high inflation rates as we consume our daily news. The default reaction to rising inflation is typically in relation to rising...
American Rescue Plan Act of 2021: Medicaid Rebate Inflation Penalties Will Soon Know No BoundsOn March 11, 2021, President Joe Biden signed into law the American Rescue Plan Act of 2021 (ARP21), also known as the COVID-19 Relief Bill. Many pharmaceutical manufacturers...
Three things to know about the challenges of VA/FSS contracting.The Veterans/Federal Supply Schedule (VA/FSS) is likely the most complex and time-consuming government contracting process you will face. Public Law 102-585 requires brand manufacturers to participate in...
Mergers and Acquisitions Never End In A Tie!When it comes to corporate mergers, the acquiring company is almost always the sole beneficiary. The people in the acquired company are, unfortunately, viewed as excess baggage. This displacement of human resources typically...
Have you been lulled into complacency by a system-based government pricing solution?The idea of using a comprehensive, system-based solution for government pricing computations can be appealing. Any tool that promises compliance with complex reporting requirements for...
Understanding the complexities of implementing a generic pharmaceutical company commercialization plan.Seasoned pharma executives know that implementing a generic pharmaceutical company commercialization plan in the US market is a complex exercise in multi-tasking....
System-based calculations miss crucial details in government price reporting.When you have complete visibility into the process driving your government pricing computations, you have control. You gain certainty and confidence knowing your monthly and quarterly...